NCT05057351View on ClinicalTrials.gov

A Controlled Study to Evaluate the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic Dermatitis

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

November 30, 2020

Study Completion Date

March 31, 2021

Conditions

Mild to Moderate Atopic Dermatitis

Interventions

OTHER

Isopentenyltheophylline 0.44% + Glycerin 4.56%

Application of topical cream twice a day on the area affected by Atopic Dermatitis

OTHER

Glycerin 4.56%

Application of topical cream twice a day on the area affected by Atopic Dermatitis

Trial Locations (1)

27028

Complife Italia S.r.l., San Martino Siccomario

All Listed Sponsors

collaborator

Complife Italia S.r.l

UNKNOWN

lead

Greenpharma S.A.S.

OTHER

NCT05057351 - A Controlled Study to Evaluate the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic Dermatitis | Biotech Hunter | Biotech Hunter